GSK wins European regulator nod for new gene therapy

Ben Adams

GlaxoSmithKline has won a key recommendation from the the EMA today for Strimvelis–a groundbreaking new for children living with an incredibly rare and fatal condition.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS